# GETUG P05 (NCT02271659)

> Medical and Economic Evaluation for Intermediate-risk Prostate Cancer

No report yet. It can be ordered.

- Drugs tested: none (the trial tests no drug)
- Indication: intermediate-risk prostate cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02271659
- Phase: NA
- Status: UNKNOWN
- Sponsor: Hospices Civils de Lyon
- Conditions: Prostate Cancer
- Interventions: Brachytherapy boost with external beam radiotherapy; Exclusive external beam radiotherapy
- Enrollment: 298
- Primary outcome: Comparison of the biochemical relapse free survival of the patients in two groups at 5 years for an external beam radiotherapy with a brachytherapy boost versus an exclusive external beam radiotherapy

## Indexed commentary on GETUG P05 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 6

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=getug-p05-nct02271659